InnoThyroGen is a collaborative research project dedicated to improving thyroid health through innovation in genomics, machine learning, and predictive medicine. With a multidisciplinary consortium of 13 partners from Croatia and Serbia, we unite academic institutions, healthcare providers, private companies, and patient organizations to address the global challenge of thyroid diseases. Our work focuses on delivering precise diagnostic tools, personalized treatments, and sustainable healthcare solutions.
By combining expertise across research, clinical applications, and technology development, we aim to bridge the gap between groundbreaking scientific discoveries and real-world healthcare needs.
Our mission is to transform thyroid disease management by developing innovative, patient-centric solutions that incorporate advanced genomics and artificial intelligence. Millions of people worldwide suffer from thyroid disorders such as hypothyroidism, hyperthyroidism, autoimmune diseases, and thyroid cancers, often undiagnosed or poorly managed.
At InnoThyroGen, we aim to reduce these gaps in diagnosis and care by providing tools that enable early detection, optimize treatments, and improve the quality of life for patients globally.
We envision a future where healthcare systems embrace personalized medicine to enhance patient care and outcomes. By establishing Croatia and Serbia as regional hubs of excellence in thyroid health research, we are setting the foundation for a broader European and global impact. Our vision includes creating long-term, sustainable models for innovation in thyroid healthcare that integrate seamlessly into clinical practice.
Through collaboration with stakeholders across academia, industry, and government, we strive to create a blueprint for tackling complex medical challenges in other fields as well.
InnoThyroGen is driven by a mission to address pressing challenges in thyroid disease diagnosis and treatment. Through our carefully designed objectives, we seek to bridge research, clinical care, and technological innovation
Current diagnostic approaches often lead to misdiagnoses and delayed treatments for thyroid disorders. We aim to develop advanced clinical tools powered by machine learning and genomic insights to improve early detection and accurate classification of thyroid conditions, including autoimmune diseases and cancers
Every patient is unique. We leverage whole-genome sequencing, next-generation sequencing (NGS), and pharmacogenomic analysis to tailor treatments to the individual genetic and environmental profiles of patients. This approach ensures more effective and safer treatment protocols
We are establishing strong collaborative networks between academic institutions, healthcare providers, and technology firms in Croatia and Serbia. By fostering knowledge exchange and collaborative research, we are creating a dynamic environment for continued innovation in healthcare
Innovation doesn’t stop at the research stage. We actively support healthcare start-ups and spin-offs to bring research breakthroughs to market, enabling the development of new products and services that can improve clinical outcomes and patient care
Collaboration with clinicians, patients, and public authorities is critical to our success. By maintaining active engagement with these stakeholders, we ensure that our solutions are relevant, scalable, and sustainable beyond the project’s timeline
InnoThyroGen encompasses a wide array of activities designed to foster innovation, improve clinical practice, and engage stakeholders
We harness advancements in genomic technologies and machine learning to analyze complex datasets. By integrating next-generation sequencing (NGS) and polygenic risk scores (PRS), we aim to develop powerful predictive models for thyroid disease management. These tools provide healthcare professionals with actionable insights to make more accurate and timely decisions
A key focus of our project is creating user-friendly digital tools that combine genomic and clinical data to assist healthcare professionals. These solutions will seamlessly integrate with electronic health records (EHRs) to provide a comprehensive view of patient health, empowering doctors to offer personalized treatment options
We are investing in the next generation of healthcare innovators by organizing workshops, training programs, and knowledge-sharing initiatives. These efforts focus on genomics, personalized medicine, and advanced data analysis techniques, ensuring that healthcare professionals are equipped with the skills needed to adopt and apply new technologies
Patients are at the center of our innovation. We actively collaborate with patient advocacy groups to gather insights and ensure that our solutions address real-world needs. Public health authorities and healthcare providers are also key collaborators, helping to shape the practical application of our tools in clinical settings
To ensure the long-term impact of our innovations, we are developing business models and commercialization strategies for new healthcare solutions. We collaborate with private companies and investors to bring our research findings to market, creating a sustainable pathway for ongoing innovation in thyroid healthcare
The work we do at InnoThyroGen is set to make a lasting impact on healthcare systems, clinical practices, and patient outcomes
Our machine-learning-powered diagnostic tools will revolutionize how thyroid disorders are detected and classified. By enabling earlier and more accurate diagnoses, we can significantly reduce the risk of complications and improve patient outcomes
Through the integration of pharmacogenomics and advanced data analytics, we are enabling clinicians to tailor treatments to each patient’s unique genetic profile. This personalized approach ensures better treatment outcomes and minimizes adverse side effects
InnoThyroGen’s digital health solutions will provide healthcare professionals with the resources they need to make informed decisions quickly and accurately. These tools streamline clinical workflows and enhance the quality of care
By fostering collaboration among academic institutions, technology firms, and healthcare providers, we are creating a robust innovation ecosystem in Croatia and Serbia. This network will continue to drive advancements in personalized medicine and healthcare innovation long after the project concludes
At the heart of InnoThyroGen is a commitment to improving the lives of patients. Our innovations will ensure that individuals living with thyroid disorders receive accurate diagnoses, effective treatments, and compassionate care that addresses their unique needs
By supporting the growth of healthcare start-ups and fostering the commercialization of new solutions, we are contributing to the economic development of the region. Our project serves as a catalyst for entrepreneurship and business innovation in healthcare
The InnoThyroGen project has received funding from the European Union’s HORIZON programme with Project Number: 101187880
Copyright © 2025 All rights reserved.
